THE FUTURE OF PET MEDICINE
Lifescient, Inc., is a veterinary pharmaceutical company revolutionizing pet medicine with the development of long-acting injectables (LAIs) to replace daily dosing. Our innovation will provide freedom for pet parents, improved quality of care for pets, and an additional revenue source for veterinary clinics. There are numerous conditions in pets for which there is a need for improved treatment options. Lifescient’s LAIs will address these needs and capture this market with a robust product portfolio.
There is a lack of medications developed specifically for pets and human medications are frequently prescribed. Our strategy is to reformulate these medications into injectable formulations, guaranteeing prescription compliance and improving clinical results. The technical feasibility has been established and the proof of concept of our proprietary drug delivery platform has been demonstrated with several medications. This will enable us to address conditions across multiple therapeutic classes and species.
Lifescient is dedicated to improving the quality of care for our pets through innovative long-acting drug delivery technology.
BENEFITS OF LONG ACTING INJECTABLES
Our team has developed long-acting injectables which, when placed in the pet subcutaneously, similar to the placement of a microchip, will release medication continuously in a controlled manner for weeks and months at a time. Long-acting injectables are safely absorbed by the body and do not have to be removed.
LAIs offer:
- Freedom from the stress and commitment required of daily dosing;
- Guaranteed prescription compliance increasing the likelihood of successful treatment;
- Strengthening the bond between veterinarian and pet parents leading to improved care;
- Minimized side effects due to drug release remaining in the therapeutic window.